ARCHIVES

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

Professional Societies: AACR Presents Awards At Annual Meeting

April 18, 1997

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

December 6, 2002